News

Search EMA's news announcements

Resultados (3794)

Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022

30 Septiembre 2022

News Corporate

New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome

30 Septiembre 2022

News Human Medicines Referrals

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022

30 Septiembre 2022

News Human Pharmacovigilance Referrals

EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products

29 Septiembre 2022

News Human Advanced therapies Medicines

New co-chairs elected for working parties for healthcare professionals and for patients and consumers

23 Septiembre 2022

News Corporate

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022

22 Septiembre 2022

News Human COVID-19 Medicines

Biosimilar medicines can be interchanged

19 Septiembre 2022

News Human Corporate Biosimilars

New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection

16 Septiembre 2022

News Human Medicines

EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines

16 Septiembre 2022

News Human COVID-19 Vaccines

Adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2 recommended for approval

12 Septiembre 2022

News Human COVID-19 Vaccines